EuroPMP members attended the 4th annual Nordic Peritoneal Oncology group meeting on March 9th, 2022 in Helsinki, Finland On Wednesday March 9th, the Nordic Peritoneal Oncology group was again able to organise a face-to-face meeting in Helsinki. Participants from peritoneal oncology centers in Denmark, Norway, Sweden and Finland participated, many of whom are also members of the EuroPMP COST Action, including Dr Anna Lepistö, who hosted the meeting. The Helsinki team had put together a varied and interesting scientific program, focusing on the clinical and research activities from the past two years at the participating centers, including activities relating to PMP. Of particular interest regarding the clinical activities, EuroPMP members…
Incidence and Prevalence in Europe
EuroPMP member researchers from Norway and the United Kingdom have recently published a paper giving a sound scientific footing for the incidence and prevalence of PMP in Europe. The research suggests that the previous incidence estimate of 1-2 persons per million is too low, with a more realistic figure being around 3.2 persons per million. The prevalence was estimated to be around 22 persons per million in Europe, meaning 11,726 people living with active disease in 2018. The incidence and prevalence paper can be read here.
New STSM to Oslo
Yaroslaw Sautkin, a EuroPMP member from Germany, has completed a Short-Term Scientific Mission to Professor Kjersti Flatmark’s Translational Cancer Therapy lab at Oslo University Hospital’s Institute for Cancer Research. While on his STSM, Yaroslaw learned more about the use of experimental animal models for pseudomyxoma peritonei (PMP) in order to further the work that his own institution, the University of Tübingen, is undertaking into the use of PIPAC with mucolytic substances. Yaroslaw’s visit allowed members of both teams to meet and share knowledge, leading to stronger synergies between their researchers. Both groups are now looking forward to working on research projects together in the future. STSMs are offered several times…